Invention Grant
- Patent Title: Insulin-Fc fusion proteins and methods of use to treat cancer
-
Application No.: US17814285Application Date: 2022-07-22
-
Publication No.: US11667689B2Publication Date: 2023-06-06
- Inventor: Todd C. Zion , Thomas M. Lancaster
- Applicant: Akston Biosciences Corporation
- Applicant Address: US MA Beverly
- Assignee: Akston Biosciences Corporation
- Current Assignee: Akston Biosciences Corporation
- Current Assignee Address: US MA Beverly
- Agency: Hovey Williams LLP
- Main IPC: C07K14/62
- IPC: C07K14/62 ; A61P3/10 ; A61K9/00 ; C07K14/435 ; C12N15/62
Abstract:
The present disclosure relates to compositions of fusion proteins, e.g., insulin-Fc fusion proteins, and their use to treat cancer cells and cancer tumors.
Public/Granted literature
- US20230072260A1 INSULIN-FC FUSION PROTEINS AND METHODS OF USE TO TREAT CANCER Public/Granted day:2023-03-09
Information query
